Most human granulosa cell tumors express c-MET: A potential new therapeutic target
Physiology International · 01.07.2026 · 113 (2) · 299-310
DOI: 10.1556/2060.2026.00825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiology International, erschienen am 01.07.2026. Verfasst von Edina A Wappler-Guzzetta und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Pathology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA. Hauptthemen laut MEDLINE: Granulosa Cell Tumor, Proto-Oncogene Proteins c-met, Ovarian Neoplasms. Die Arbeit nennt 116 Literaturangaben.
Abstract (Originalsprache)
Objectives
The transmembrane receptor tyrosine kinase c-MET has a central role in granulosa cells in many physiological and pathological processes of granulosa cells, including cell survival and folliculogenesis. We therefore hypothesized that c-MET may be expressed in granulosa cell tumors (GCTs). Methods c-MET immunostaining was performed retrospectively on human GCT specimens, including adult ( n = 19) and juvenile GCTs ( n = 2). Data was collected on patient demographics, tumor stage, and size. Furthermore, staining intensity was analyzed by a staining intensity score, and the presence or absence of membranous staining was noted. Multivariate logistic regression was used for statistical analysis, with P < 0.05 being considered statistically significant. Juvenile GCTs were excluded from the statistical analysis.
Results
Both cytoplasmic and membranous staining was seen in GCT tissues, with the majority (∼74%) of the adult and both juvenile cases showing positive membranous staining. As expected, vascular endothelial cells were also c-MET positive in the tumor tissue. Amongst the adult GCT patients, tumor mitotic activity was higher with older age ( r = 0.531; P = 0.019). Also, smaller tumors had higher c-MET intensity scores ( r = −0.579, P = 0.038).
Conclusions
Most GCTs were c-MET positive by immunostaining along with the vascular endothelial cells, highlighting the potential of c-MET inhibition as a therapeutic option in these tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Pathology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
- 2Department of Pathology and Laboratory Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA, 02118, USA.
- 3Department of Pathology, Providence Cedars-Sinai Tarzana Medical Center, Tarzana, CA, 91356,USA.
ORCID-Profile: Edina A Wappler-Guzzetta
Zitieren
APA
Wappler-Guzzetta, E. A., Real, D. M., Aman, S., Huang, C., Deisch, J. K., & Denham, L. J. (2026). Most human granulosa cell tumors express c-MET: A potential new therapeutic target. Physiology International, 113(2), 299-310. https://doi.org/10.1556/2060.2026.00825
Vancouver
Wappler-Guzzetta EA, Real DM, Aman S, Huang C, Deisch JK, Denham LJ. Most human granulosa cell tumors express c-MET: A potential new therapeutic target. Physiology International. 2026;113(2):299-310. doi:10.1556/2060.2026.00825
BibTeX
@article{WapplerGuzzetta2026,
author = {Wappler-Guzzetta, Edina A and Real, Daniel M and Aman, Shehla and Huang, Chelsea and Deisch, Jeremy K and Denham, Laura J},
title = {Most human granulosa cell tumors express c-MET: A potential new therapeutic target},
journal = {Physiology International},
year = {2026},
volume = {113},
number = {2},
pages = {299--310},
doi = {10.1556/2060.2026.00825}
}
EUVIMED